Jyong Biotech (MENS) Treasury Shares (2024 - 2025)
Jyong Biotech (MENS) posted quarterly Treasury Shares of $16.4 million for Q4 2025, little changed year-over-year from $16.4 million in Q4 2024, and little changed quarter-over-quarter from $16.4 million in Q4 2024.
Jyong Biotech (MENS) Treasury Shares (2024 - 2025) Analysis & Trends
Jyong Biotech's Treasury Shares history runs 2 years deep, the most recent figure standing at $16.4 million for Q4 2025.
- In Q4 2025, Treasury Shares changed 0.0% year-over-year to $16.4 million; the TTM figure through Dec 2025 stood at $16.4 million (changed 0.0% YoY), while the FY2025 annual figure was $16.4 million, changed 0.0% from the prior year.
- Treasury Shares for Q4 2025 stood at $16.4 million, roughly flat from $16.4 million in the prior quarter.
- The five-year high for Treasury Shares was $16.4 million in Q4 2024, with the low at $16.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Jyong Biotech | 159.89 Mn | 159.89 Mn | - | 16.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.37 Mn |
| Dec 31, 2025 | 16.37 Mn |
| Dec 31, 2024 | 16.37 Mn |
| Dec 31, 2024 | 16.37 Mn |